Matthew Schrag

Matthew Schrag, a physician and neuroscientist who investigates research integrity and exposed major problems in Alzheimer’s studies, discusses the amyloid hypothesis and how image manipulation and institutional pressures shaped the field. He describes forensic review, the Cassava Sciences controversy, evolving detection tools and the social forces that kept a flawed paradigm alive.

Join Dr. Matthew Schrag, a neuroscientist known for exposing fraud in Alzheimer's research, alongside investigative journalist Charles Piller, as they delve into the ethics of scientific integrity. Dr. Dale Bredesen, renowned for his work on Alzheimer's, discusses alternative treatment approaches amid controversy over drug efficacy and manipulated data. They tackle the amyloid hypothesis, the significance of lifestyle factors like diet, and the need for transparency in research. Plus, discover insights on genetic risk factors and proactive measures to enhance brain health.

Albert Bourla, CEO of Pfizer, discusses the company's focus on innovative cancer treatments and the role of AI in drug development. Ray Dalio shares insights on rising global debt, urging smart management for economic stability. Matthew Schrag, a neurologist at Vanderbilt, raises red flags about research integrity in Alzheimer's treatments, stressing the urgent need for accountability in scientific studies. Together, they explore the intersection of healthcare innovation and economic challenges, emphasizing the importance of prioritizing effective therapies.